Canada markets close in 24 minutes

ANEW MEDICAL, INC. (LEAS)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00020.0000 (0.00%)
As of 02:21PM EDT. Market open.

ANEW MEDICAL, INC.

13576 Walnut Street
Omaha, NE 68144
United States
480 254 5871
https://www.anewmeds.com

Sector(s)Industrials
IndustryRental & Leasing Services
Full Time Employees1

Key Executives

NameTitlePayExercisedYear Born
Mr. Peter J. MoriartyChief Operating Officer10kN/AN/A
Dr. Joseph Sinkule Ph.D.Founder, CEO, CFO, Chairman of the Board & SecretaryN/AN/A1954
Dr. Miguel Chillon RodriguezChief Scientific Officer & ConsultantN/AN/AN/A
Dr. Shalom Hirshman M.D.Chief Medical Officer of Emeritus & Independent Director – NomineeN/AN/A1940
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ANEW MEDICAL, INC. focuses on developing biologic medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. The company is based in Omaha, Nebraska.

Corporate Governance

ANEW MEDICAL, INC.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.